Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $8.37 $8.37 Tuesday, 30th May 2023 CNCE stock ended at $8.37. During the day the stock fluctuated 0% from a day low at $8.37 to a day high of $8.37.
90 days $8.35 $8.55
52 weeks $3.90 $8.55

Historical Concert Pharmaceuticals prices

Date Open High Low Close Volume
Feb 10, 2022 $3.07 $3.64 $3.06 $3.26 386 900
Feb 09, 2022 $3.08 $3.15 $2.99 $3.13 65 100
Feb 08, 2022 $3.19 $3.19 $3.02 $3.05 112 700
Feb 07, 2022 $3.22 $3.32 $3.10 $3.18 81 400
Feb 04, 2022 $3.10 $3.21 $3.02 $3.19 35 300
Feb 03, 2022 $3.36 $3.36 $3.06 $3.10 120 700
Feb 02, 2022 $3.38 $3.42 $3.10 $3.40 116 500
Feb 01, 2022 $3.06 $3.40 $3.06 $3.39 44 971
Jan 31, 2022 $2.86 $3.13 $2.86 $3.03 78 600
Jan 28, 2022 $2.85 $2.90 $2.76 $2.89 117 100
Jan 27, 2022 $2.95 $2.99 $2.79 $2.90 104 500
Jan 26, 2022 $2.97 $3.05 $2.88 $2.91 49 500
Jan 25, 2022 $3.04 $3.04 $2.93 $2.93 42 800
Jan 24, 2022 $2.99 $3.12 $2.80 $3.04 129 500
Jan 21, 2022 $3.06 $3.13 $2.91 $3.11 122 800
Jan 20, 2022 $3.00 $3.14 $3.00 $3.06 55 800
Jan 19, 2022 $3.05 $3.10 $3.00 $3.01 97 000
Jan 18, 2022 $3.10 $3.15 $3.00 $3.01 60 300
Jan 14, 2022 $3.12 $3.16 $3.00 $3.15 38 100
Jan 13, 2022 $3.10 $3.14 $3.03 $3.06 28 500
Jan 12, 2022 $3.24 $3.26 $3.09 $3.12 34 400
Jan 11, 2022 $3.04 $3.32 $3.04 $3.26 74 300
Jan 10, 2022 $3.08 $3.14 $3.01 $3.03 65 300
Jan 07, 2022 $3.05 $3.19 $3.03 $3.09 23 200
Jan 06, 2022 $3.08 $3.20 $3.00 $3.08 90 500

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use CNCE stock historical prices to predict future price movements?
Trend Analysis: Examine the CNCE stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the CNCE stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Concert Pharmaceuticals

Concert Pharmaceuticals Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologi... CNCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT